palmidrol has been researched along with luteolin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 8 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ahmad, A; Campolo, M; Crupi, R; Cuzzocrea, S; Esposito, E; Paterniti, I | 1 |
| Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Navarra, M; Paterniti, I | 1 |
| Ahmad, A; Britti, D; Campolo, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Morittu, VM; Peli, A | 1 |
| Campolo, M; Cordaro, M; Cornelius, C; Cuzzocrea, S; Esposito, E; Navarra, M; Paterniti, I; Siracusa, R | 1 |
| Barbierato, M; Bruschetta, G; Cuzzocrea, S; Facci, L; Giusti, P; Impellizzeri, D; Skaper, SD; Zusso, M | 1 |
| Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Impellizzeri, D; Paterniti, I; Siracusa, R | 1 |
| Argentini, C; Barbierato, M; Facci, L; Giusti, P; Marinelli, C; Skaper, SD; Zusso, M | 1 |
| Bruschetta, G; Caltagirone, C; Cisari, C; Cordaro, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Schievano, C | 1 |
| Benarese, M; Fusco, M; Iorio, R; Lanzillotta, A; Mota, M; Parrella, E; Pizzi, M; Porrini, V; Spano, P; Tonin, P | 1 |
| Bertolino, B; Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Impellizzeri, D; Siracusa, R | 1 |
| Barbierato, M; Facci, L; Skaper, SD | 1 |
| Assogna, M; Bonnì, S; Borghi, I; Caltagirone, C; Casula, EP; D'Acunto, A; Di Lorenzo, F; Koch, G; Martorana, A; Minei, M; Motta, C; Porrazzini, F; Samà , D | 1 |
| Brenner, MJ; Cingolani, C; D'Ascanio, L; Di Stadio, A; Maranzano, M; Vitelli, F | 1 |
| Ardizzone, A; Campolo, M; Cardali, SM; Casili, G; Conti, A; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Scuderi, SA; Siracusa, R | 1 |
| Brenner, MJ; Camaioni, A; Cantone, E; Cingolani, C; D'Ascanio, L; De Luca, P; De Riu, G; De Vincentiis, M; Di Stadio, A; Ferreli, F; La Mantia, I; Motta, G; Spriano, G; Vaira, LA; Vitelli, F | 1 |
| Brenner, MJ; Camaioni, A; Carriere, G; De Luca, P; Di Stadio, A; Marra, P; Montemurro, N; Pucci, R; Ricciardi, L; Salzano, G | 1 |
| Ajello, V; Alibardi, A; Assogna, M; Bonini, I; Dezi, S; Engl, M; Ferrazzoli, D; Koch, G; Kofler, M; Maestri, R; Ortelli, P; Pucks-Faes, E; Saltuari, L; Sebastianelli, L; Versace, V | 1 |
| Brenner, MJ; Camaioni, A; Cocuzza, S; De Luca, P; Di Stadio, A; Ferreli, F; Gaino, F; Gallina, S; Ingrassia, A; La Mantia, I; Mercante, G; Oliva, S; Pace, GM; Sireci, F | 1 |
| Bartolucci, F; Bellucci, AM; Ciaramaglia, PL; Cuzzocrea, S; Evangelista, M; Ferri, L; Lucangeli, M; Piccioni, L; Piga, A; Pirro, M; Russo, A; Russo, AM | 1 |
1 review(s) available for palmidrol and luteolin
| Article | Year |
|---|---|
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
Topics: Administration, Oral; Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Antidepressive Agents; Biological Availability; Biotransformation; Depression; Disease Models, Animal; Drug Combinations; Ethanolamines; Homeostasis; Humans; Inflammation; Luteolin; Mast Cells; Neurocognitive Disorders; Neuroglia; Neuroimmunomodulation; Palmitic Acids; Particle Size; Spinal Cord Injuries | 2015 |
5 trial(s) available for palmidrol and luteolin
| Article | Year |
|---|---|
Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
Topics: Adult; Amides; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Ethanolamines; Female; Humans; Luteolin; Male; Middle Aged; Olfaction Disorders; Palmitic Acids; Pilot Projects; Single-Blind Method; Smell | 2021 |
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.
Topics: Amides; COVID-19; Dietary Supplements; Ethanolamines; Humans; Luteolin; Olfaction Disorders; Palmitic Acids; SARS-CoV-2 | 2022 |
Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study.
Topics: Amides; COVID-19; COVID-19 Drug Treatment; Ethanolamines; Female; Humans; Longitudinal Studies; Luteolin; Male; Olfaction Disorders; Palmitic Acids; Post-Acute COVID-19 Syndrome; Smell | 2022 |
Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA
Topics: Adult; COVID-19; Evoked Potentials, Motor; Fatigue; Female; gamma-Aminobutyric Acid; Humans; Luteolin; Middle Aged; Neural Inhibition; Post-Acute COVID-19 Syndrome; Transcranial Magnetic Stimulation | 2023 |
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
Topics: COVID-19; Humans; Luteolin; Olfaction Disorders; Olfactory Training; Smell | 2023 |
14 other study(ies) available for palmidrol and luteolin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression.
Topics: Amides; Animals; Antidepressive Agents; Anxiety; Apoptosis; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Corticosterone; Dendritic Spines; Depression; Disease Models, Animal; Drug Combinations; Endocannabinoids; Ethanolamines; Luteolin; Male; Mice; Neurogenesis; Palmitic Acids | 2013 |
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury.
Topics: Amides; Animals; Blotting, Western; Cell Survival; Coloring Agents; Cyclooxygenase 2; Drug Combinations; Endocannabinoids; Ethanolamines; Inflammation; Luteolin; Mice; Nanoparticles; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Organ Culture Techniques; Palmitic Acids; Pharmaceutical Solutions; Spinal Cord Injuries; Tetrazolium Salts; Thiazoles | 2013 |
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice.
Topics: Amides; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cytokines; Endocannabinoids; Ethanolamines; Immunohistochemistry; Luteolin; Male; Mice; Mice, Inbred DBA; Palmitic Acids | 2013 |
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
Topics: Amides; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Caspase 3; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Drug Interactions; Ethanolamines; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Hippocampus; Humans; I-kappa B Proteins; In Vitro Techniques; Luteolin; Mice; Neuroblastoma; Neuroprotective Agents; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrites; Organ Culture Techniques; Palmitic Acids; Peptide Fragments | 2014 |
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury.
Topics: Amides; Animals; Autophagy; Beclin-1; DNA-Binding Proteins; Drug Combinations; Ethanolamines; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Luteolin; Male; Mice; Microtubule-Associated Proteins; Nerve Tissue Proteins; Nuclear Proteins; Palmitic Acids; Sequestosome-1 Protein; Spinal Cord Injuries | 2016 |
Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells.
Topics: Amides; Animals; Cell Differentiation; Cells, Cultured; Ethanolamines; Gene Expression Regulation; Luteolin; Myelin Basic Protein; Myelin Sheath; Neural Stem Cells; Oligodendroglia; Palmitic Acids; Protein Kinase Inhibitors; Rats; RNA, Messenger; TOR Serine-Threonine Kinases | 2015 |
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
Topics: Adult; Aged; Aged, 80 and over; Amides; Animals; Antioxidants; Behavior, Animal; Brain Ischemia; Cohort Studies; Disease Models, Animal; Drug Combinations; Ethanolamines; Female; Humans; Infarction, Middle Cerebral Artery; Inflammation; Luteolin; Male; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care; Palmitic Acids; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Stroke; Treatment Outcome | 2016 |
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia.
Topics: Amides; Animals; Brain Ischemia; Cell Degranulation; Cells, Cultured; Coculture Techniques; Ethanolamines; Glucose; L-Lactate Dehydrogenase; Luteolin; Mast Cells; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxygen; Palmitic Acids | 2016 |
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.
Topics: Amides; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Autistic Disorder; Brain; Child; Chymases; Cytokines; Disease Models, Animal; Doublecortin Domain Proteins; Enzyme Inhibitors; Ethanolamines; Follow-Up Studies; Humans; Luteolin; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neuropeptides; Nitric Oxide Synthase Type II; Palmitic Acids; Tryptases; Valproic Acid | 2017 |
Oligodendrocyte Progenitor Cell Cultures: A Model to Screen Neurotrophic Compounds for Myelin Repair.
Topics: Amides; Animals; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Ethanolamines; Luteolin; Myelin Sheath; Nerve Regeneration; Neuroprotective Agents; Oligodendrocyte Precursor Cells; Palmitic Acids; Rats | 2018 |
Effects of Palmitoylethanolamide Combined with Luteoline on Frontal Lobe Functions, High Frequency Oscillations, and GABAergic Transmission in Patients with Frontotemporal Dementia.
Topics: Activities of Daily Living; Aged; Amides; Cognition; Ethanolamines; Evoked Potentials, Motor; Female; Frontotemporal Dementia; Humans; Luteolin; Male; Middle Aged; Neural Inhibition; Neurodegenerative Diseases; Palmitic Acids; Transcranial Magnetic Stimulation | 2020 |
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury.
Topics: Administration, Oral; Adult; Aged; Amides; Animals; Brain Injuries, Traumatic; Disease Models, Animal; Drug Therapy, Combination; Ethanolamines; Female; Humans; Luteolin; Male; Memory, Short-Term; Mice; Middle Aged; Morris Water Maze Test; Neurogenesis; Palmitic Acids; Random Allocation; Spatial Learning; Treatment Outcome | 2021 |
What Is the Role of Palmitoylethanolamide Co-Ultramicronized with Luteolin on the Symptomatology Reported by Patients Suffering from Long COVID? A Retrospective Analysis Performed by a Group of General Practitioners in a Real-Life Setting.
Topics: COVID-19; General Practitioners; Humans; Luteolin; Post-Acute COVID-19 Syndrome; Retrospective Studies; SARS-CoV-2 | 2023 |